Modulation of growth hormone action during growth hormone replacement in growth hormone-deficient women: comparison of raloxifene and oral oestrogen.

Trial Profile

Modulation of growth hormone action during growth hormone replacement in growth hormone-deficient women: comparison of raloxifene and oral oestrogen.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Estradiol; Raloxifene
  • Indications Hypopituitarism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top